Table 3 New users: Hazard ratio of treatment discontinuation
Cox Model Hazard Ratio a (95% confidence interval) b | |||
|---|---|---|---|
15-day gap n = 30,507 | 30-day gap n = 30,507 | 60-day gap n = 30,507 | |
Erenumab | 1.48 (1.20, 1.90) | 1.25 (0.99, 1.66) | 1.08 (0.80, 1.54) |
Fremanezumab | 1.68 (1.36, 2.16) | 1.45 (1.13, 1.95) | 1.26 (0.92, 1.80) |
Galcanezumab | 1.55 (1.25, 1.97) | 1.27 (0.99, 1.68) | 1.11 (0.82, 1.59) |
OnabotulinumtoxinA | 1.17 (0.95, 1.49) | 1.07 (0.84, 1.43) | 1.09 (0.82, 1.54) |
Eptinezumab | Reference | Reference | Reference |